UC San Diego Joins Second Major National Clinical Trial for Novel Coronavirus

UC San Diego Health will be part of the Phase III national AstraZeneca clinical trial that will recruit up to 30,000 participants at multiple sites across the country to assess the safety and efficacy of a vaccine to prevent COVID-19.

Click to view original post

Advertise With Us